Monday, March 16, 2026

5:00 PM - 7:00 PM
Welcome Cocktail Reception

Tuesday, March 17, 2026

7:30 AM - 8:30 AM
Breakfast
8:30 AM - 8:45 AM
Conference Welcome Remarks
  • Paula B. Fein, MSEd
    Vice President | Drug Channels Institute
8:45 AM - 9:15 AM
Keynote: The State of the Drug Channel 2026
  • Adam J. Fein, PhD
    President | Drug Channels Institute
9:15 AM - 10:00 AM
Fireside Chat with Debbie Weitzman
  • Panelist
    Debbie Weitzman
    CEO, Pharmaceutical & Specialty Solutions | Cardinal Health
  • Moderator
    Adam J. Fein, PhD
    President | Drug Channels Institute
10:00 AM - 10:15 AM
Coffee Break
10:15 AM - 11:00 AM
Wall Street Controversies on Drug Channel Companies
  • Elizabeth Anderson Headshot
    Panelist
    Elizabeth Anderson, MBA
    Senior Managing Director | Evercore ISI
  • Cherny headshot
    Panelist
    Michael Cherny
    Senior Managing Director | Leerink Partners
  • George Headshot
    Panelist
    George Hill
    Managing Director & Lead Analyst, Healthcare Technology & Service | Deutsche Bank Securities Inc.
  • Tyler Headshot
    Moderator
    Tyler Novotny
    Senior Vice President | Drug Channels Institute
11:00 AM - 11:45 AM
What's Next for Provider-Administered Drugs and Buy-and-Bill
  • Jan headshot
    Panelist
    Saira A. Jan, MS, PharmD
    Vice President & Chief Pharmacy Officer | Horizon Blue Cross Blue Shield of New Jersey
  • Panelist
    Debra Patt, MD, PhD, MBA
    Executive Vice President, Policy and Strategy | Texas Oncology
  • Thompson Smith headshot
    Panelist
    Lisa Thompson Smith, RPh
    SVP & President, Specialty Distribution and Solutions | Cencora
  • Sullivan headshot
    Moderator
    Milena Sullivan
    Partner, Market Access | Blue Matter Consulting
11:45 AM - 1:00 PM
Lunch
1:00 PM - 2:00 PM
Keynote + Fireside Chat with Eric Percher
  • Percher headshot
    Keynote Speakear
    Eric Percher
    Co-Founder Nephron Research, Lead Analyst Drug Channel & Digital Health | Nephron Research
  • Moderator
    Adam J. Fein, PhD
    President | Drug Channels Institute
2:00 PM - 2:45 PM
Fireside Chat with Mostafa Kamal
  • Panelist
    Mostafa Kamal
    President and Chief Executive Officer | Prime Therapeutics
  • Moderator
    Adam J. Fein, PhD
    President | Drug Channels Institute
2:45 PM - 3:00 PM
Coffee Break
3:00 PM - 3:45 PM
Crossfire: The 340B Drug Pricing Program
  • Panelist
    John M. O'Brien, PharmD, MPH
    President and Chief Executive Officer | National Pharmaceutical Council
  • Testoni headshot
    Panelist
    Maureen Testoni, JD
    President and Chief Executive Officer | 340B Health
  • Luke Greenwalt Headshot
    Moderator
    Luke Greenwalt, MBA
    VP and Lead, IQVIA Thought Leadership & Innovation | IQVIA
3:45 PM - 4:30 PM
Fireside Chat with Kevin Host
  • Host Headshot
    Panelist
    Kevin Host, PharmD
    Senior Vice President, Pharmacy | Walmart
  • Moderator
    Adam J. Fein, PhD
    President | Drug Channels Institute
4:30 PM - 5:15 PM
Fireside Chat with Mark Cuban
  • Mark Cuban Headshot
    Panelist
    Mark Cuban
    Entrepreneur and Co-Founder | Cost Plus Drugs
  • Moderator
    Adam J. Fein, PhD
    President | Drug Channels Institute
6:00 PM - 8:00 PM
Outdoor Dinner Reception

Wednesday, March 18, 2026

7:30 AM - 8:30 AM
Breakfast
8:30 AM - 9:30 AM
Keynote + Fireside Chat with Antonio Ciaccia
  • Keynote Speaker
    Antonio Ciaccia
    President | 3 Axis Advisors , Chief Executive Officer | 46brooklyn Research
  • Moderator
    Adam J. Fein, PhD
    President | Drug Channels Institute
9:30 AM - 10:15 AM
The View from the Payer
  • Gremminger Headshot
    Panelist
    Shawn Gremminger
    President and CEO | The National Alliance of Healthcare Purchaser Coalitions
  • Panelist
    Mike Jansen
    Senior Director, Benefits & Wellbeing | Walmart Stores, Inc.
  • Panelist
    Rosa Novo
    Administrative Benefits Director | Miami-Dade County Public Schools
  • Bryce Platt Headshot
    Moderator
    Bryce Platt, PharmD, RPh
    Director | Drug Channels Institute
10:15 AM - 10:30 AM
Coffee Break
10:30 AM - 11:15 AM
How Patient-Paid Prescriptions are Changing the Drug Channel
  • Laura Jensen headshot
    Panelist
    Laura Jensen, MBA
    Chief Commercial Officer and President of Pharma Solutions | GoodRx
  • Love headshot
    Panelist
    John Love
    Vice President | Amazon Pharmacy
  • Panelist
    Jennifer Mazur, MBA
    General Manager, US LillyDirect; Senior Vice President, Lilly USA Consumer Hub | Eli Lilly and Company
  • Moderator
    Jailendra Singh, MBA
    Managing Director | Truist Securities
11:15 AM - 12:00 PM
The Perspective from Market Access
  • Panelist
    Jeff Davis
    Executive Director, National Channel | AstraZeneca
  • Christine Photo
    Panelist
    Christine G. Marsh, MBA
    Senior Vice President, Value & Access | Boehringer Ingelheim
  • Norton headshot
    Panelist
    Jennifer Norton
    Former Senior Vice President, Patient and Market Access | Takeda Pharmaceuticals
  • Moderator
    Adam J. Fein, PhD
    President | Drug Channels Institute
12:00 PM - 12:05 PM
Conference Closing Remarks
  • Adam J. Fein, PhD
    President | Drug Channels Institute
Back to top